Signature Resources Capital Management, LLC Virpax Pharmaceuticals, Inc. Transaction History

Signature Resources Capital Management, LLC

  • $109 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
BUY
$0.24 - $0.82 $120 - $410
500 New
500 $160,000

About Virpax Pharmaceuticals, Inc.

VRPX Quotes by TradingView
  • Ticker VRPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,714,600
  • Market Cap $7.15M
  • Description
  • Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...
More about VRPX
Track This Portfolio

Track Signature Resources Capital Management, LLC Portfolio

Follow Signature Resources Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Resources Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Resources Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email